News
Patients who received oral tranexamic acid 500 mg daily for 3 months had reduced melasma severity and systemic inflammation markers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback